Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Lymphoid 1

Conditions

Sarcoma, Synovial 2Liposarcoma, Myxoid 2Sezary Syndrome 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

pazopanib 4tazemetostat 3Doxorubicin 3cixutumumab 2Sorafenib 2Radiotherapy 2Radiation 2Interferon-gamma 2Ifosfamide 2Gemcitabine 2tremelimumab 1temsirolimus 1sapanisertib 1romidepsin 1pembrolizumab 1lorvotuzumab mertansine 1liposomal doxorubicin 1interferon gamma-1b 1indolepropanol phosphate 1durvalumab 1atezolizumab 1Watchful Waiting 1Surgical Procedures, Operative 1Sunitinib 1Rifampin 1Razoxane 1Ramucirumab 1Radiotherapy, Conformal 1Observation 1Leukapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Sarcoma, Synovial × Interferon-gamma × Clear all
NCT03063632 2023-10-25

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
28 enrolled 15 charts
LymphoidSarcoma

Mycosis Fungoides, Sezary Syndrome, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT01957709 2019-07-10

Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma

Fred Hutchinson Cancer Center

Phase EARLY_PHASE1 Terminated
8 enrolled 9 charts
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡